Table 3. Influences on test-adjusted chlamydia notification rates by sex, New South Wales, Australia, 2000 to 2010.
| Males | Females | |||||||
|---|---|---|---|---|---|---|---|---|
| Rate ratio | 95% CI | LR Test (DF) | p | Rate ratio | 95% CI | LR Test (DF) | p | |
| Year (trend) | 0.96 | 0.94–0.99 | 6.68 (1) | 0.0098 | 0.95 | 0.93–0.96 | 37.67 (1) | < 0.0001 |
| Age group | ||||||||
| (REF: ≥ 45 years) | 519.41 (4) | < 0.0001 | 536.62 (4) | < 0.0001 | ||||
| 15–19 years | 3.59 | 3.21–4.01 | 4.70 | 3.74–5.90 | ||||
| 20–24 years | 2.76 | 2.35–3.25 | 3.26 | 2.50–4.27 | ||||
| 25–34 years | 2.07 | 1.80–2.39 | 1.97 | 1.58–2.47 | ||||
| 35–44 years | 1.32 | 1.17–1.50 | 1.05 | 0.88–1.27 | ||||
| Remoteness areas | ||||||||
| (REF: Rural and remote) | 62.42 (2) | < 0.0001 | 55.73 (2) | < 0.0001 | ||||
| Metropolitan | 1.45 | 1.32–1.59 | 1.38 | 1.27–1.50 | ||||
| Inner regional | 1.29 | 1.17–1.41 | 1.29 | 1.18–1.41 | ||||
| Socioeconomic disadvantage | ||||||||
| (REF: Low) | 31.99 (2) | < 0.0001 | 32.33 (2) | < 0.0001 | ||||
| Middling | 1.20 | 1.12–1.28 | 1.22 | 1.14–1.30 | ||||
| High | 1.06 | 0.98–1.16 | 1.15 | 1.06–1.24 | ||||
| Medicare provider density | ||||||||
| (REF: Low) | 35.30 (2) | < 0.0001 | Not included in female model | |||||
| Middling | 0.73 | 0.61–0.88 | ||||||
| High | 1.02 | 0.84–1.23 | ||||||
| Year * MPD | ||||||||
| (REF: Low) | 36.99 (2) | < 0.0001 | Not included in female model | |||||
| Middling | 1.03 | 1.00–1.06 | ||||||
| High | 0.98 | 0.95–1.01 | ||||||
Note: Year (trend) centred at 1999; adjusted model – adjusted using the logarithm of the directly age-standardized testing rate per 100 000 person years.
CI, confidence interval; LR, likelihood ratio; DF, degrees of freedom; p, probability value; and MPD, medicare provider density